Behavioral Health Issues Clinical Pathway — Emergency Department
Behavioral Health Issues Clinical Pathway — Emergency Department
Medications
General Considerations
- Review with Psychiatry whenever possible
- Consider:
- Underlying etiology of agitation
- Previous medications that yielded a positive or negative response
- Current home medications and potential interactions
- Giving current prescribed medications, consider an extra dose or an early dose
- Children may require repeat/higher doses than those usually recommended to achieve results
- If inadequate results with multiple doses of a 1st medication, consider adding another therapeutic class of medication
- Be mindful of onset of action, allow time for the medication to take effect
- Assess need for more frequent vital signs based on medication effect
Medications for Agitation
Administer medications as quickly as possible to allow continued medical evaluation/treatment For additional dosing information, see CHOP Formulary.
Medications by Diagnosis
Delirium, Developmental Delay or Autism
Delirium |
|
---|---|
Developmental Delay or Autism |
|
Clear Psychiatric Diagnosis
Catatonia | Lorazepam |
---|---|
ADHD |
|
Anxiety, trauma, PTSD |
|
Oppositional Defiant Disorder (ODD) Conduct Disorder (CD) |
|
Mania/Psychosis |
|
Unknown Etiology
Mild Agitation | Behavioral and environmental strategies to deescalate |
---|---|
Moderate Agitation |
|
Severe Agitation |
|
Unknown Substance Intoxication | Lorazepam +/- haloperidol (If severely agitated/hallucinating) |
Medications
Drug | Route | Dose, Max Dose | Onset, Duration | Comments |
---|---|---|---|---|
Chlorpromazine | IM, PO |
|
|
|
Diphenhydramine | IV, IM, PO |
|
|
|
Haloperidol | PO, IM |
|
|
|
Lorazepam | IV, IM, PO |
|
|
|
Midazolam | IN |
|
|
May repeat in 20 min |
Olanzapine | PO |
|
|
|
Risperidone | PO |
|
|
|
Medications for Violent Children– Imminent Danger to Staff, Self and/or Property
Note
If muscle stiffness or movement problems develop after use of an antipsychotic: Give diphenhydramine 1 mg/kg/dose PO/IM/IV (max 50 mg). IV route is preferred.
If persistent symptoms:
- Consider second dose of diphenhydramine
- Consider benztropine PO/IM 0.05 mg/kg/dose for children > 3 years of age (not recommended for children < 3 due to serious adverse events such as severe anhidrosis or fatal hyperthermia)
Monitoring the Child
- Baseline EKG, Continuous CR Monitor and pulse oximetry are optimal
- Assess MS, HR, RR and effort, oxygen saturation
- Please refer to standard operating processes